Table 2 Patients With Elevated Hematocrit Levels and WBC Counts During the Follow-Up Period
From: Cytoreductive treatment patterns among US veterans with polycythemia vera
Laboratory Value, n/N (%)a | Patients With PV |
|---|---|
≥1 elevated hematocrit levelb | |
12-month follow-up period | 5350/6230 (85.9) |
24-month follow-up period | 6167/6974 (88.4) |
36-month follow-up period | 6397/7115 (89.9) |
48-month follow-up period | 6492/7140 (90.9) |
Entire follow-up period | 6544/7142 (91.6) |
≥1 elevated WBC countc | |
12-month follow-up period | 2163/6280 (34.4) |
24-month follow-up period | 2851/6966 (40.9) |
36-month follow-up period | 3239/7113 (45.5) |
48-month follow-up period | 3494/7136 (49.0) |
Entire follow-up period | 3671/7137 (51.4) |